Skip to content
Ioxilan
Oxilan (ioxilan) is a small molecule pharmaceutical. Ioxilan was first approved as Oxilan-300 on 1995-12-21.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ioxilan
Tradename
Company
Number
Date
Products
OXILAN-300GuerbetN-020316 DISCN1995-12-21
1 products
OXILAN-350GuerbetN-020316 DISCN1995-12-21
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08A: X-ray contrast media, iodinated
— V08AB: Watersoluble, nephrotropic, low osmolar x-ray contrast media
— V08AB12: Ioxilan
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal insufficiencyD051437HP_0000083N19———2—2
HypothyroidismD007037EFO_0004705E03.9———1—1
Diabetes mellitusD003920EFO_0000400E08-E13———1—1
Coronary artery diseaseD003324I25.1———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190D461————1
Myeloid leukemia acuteD015470C92.01————1
Multiple myelomaD009101C90.01————1
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_00003401————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIOXILAN
INNioxilan
Description
Ioxilan is a diagnostic contrast agent. It is injected intravenously before taking X-ray images to increase arterial contrast in the final image. It was marketed in the US under the trade name Oxilan by Guerbet, L.L.C., but has been discontinued in 2017.
Classification
Small molecule
Drug classiodine-containing contrast media
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I
Identifiers
PDB—
CAS-ID107793-72-6
RxCUI27793
ChEMBL IDCHEMBL1201075
ChEBI ID—
PubChem CID3743
DrugBankDB09135
UNII IDA4YJ7J11TG (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 114 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3,884 adverse events reported
View more details